Co-Authors
This is a "connection" page, showing publications co-authored by Ki Hong and Jaehyeon Lee.
Connection Strength
3.705
-
Clinical Performance of the Standard Q COVID-19 Rapid Antigen Test and Simulation of its Real-World Application in Korea. Ann Lab Med. 2021 Nov 01; 41(6):588-592.
Score: 0.976
-
Letter to the Editor: The Interpretation of COVID-19 Seroprevalence Study Should Be Cautious. J Korean Med Sci. 2020 09 28; 35(38):e338.
Score: 0.905
-
Challenges and issues of SARS-CoV-2 pool testing. Lancet Infect Dis. 2020 11; 20(11):1232-1233.
Score: 0.892
-
Prevalence of a Single-Nucleotide Variant of SARS-CoV-2 in Korea and Its Impact on the Diagnostic Sensitivity of the Xpert Xpress SARS-CoV-2 Assay. Ann Lab Med. 2022 Jan 01; 42(1):96-99.
Score: 0.247
-
Guidelines for Laboratory Diagnosis of Coronavirus Disease 2019 (COVID-19) in Korea. Ann Lab Med. 2020 09; 40(5):351-360.
Score: 0.225
-
Pooling Upper Respiratory Specimens for Rapid Mass Screening of COVID-19 by Real-Time RT-PCR. Emerg Infect Dis. 2020 10; 26(10):2469-2472.
Score: 0.225
-
Performance Comparison of Five SARS-CoV-2 Antibody Assays for Seroprevalence Studies. Ann Lab Med. 2022 Jan 01; 42(1):71-78.
Score: 0.062
-
Evidence of Severe Acute Respiratory Syndrome Coronavirus 2 Reinfection After Recovery from Mild Coronavirus Disease 2019. Clin Infect Dis. 2021 11 02; 73(9):e3002-e3008.
Score: 0.061
-
Erratum: COVID-19 Molecular Testing in Korea: Practical Essentials and Answers From Experts Based on Experiences of Emergency Use Authorization Assays. Ann Lab Med. 2021 01; 41(1):126-127.
Score: 0.056
-
COVID-19 Molecular Testing in Korea: Practical Essentials and Answers From Experts Based on Experiences of Emergency Use Authorization Assays. Ann Lab Med. 2020 11; 40(6):439-447.
Score: 0.055